[HTML][HTML] COVID-19 vaccination scenarios: a cost-effectiveness analysis for Turkey

A Hagens, AÇ İnkaya, K Yildirak, M Sancar… - Vaccines, 2021 - mdpi.com
As of March 2021, COVID-19 has claimed the lives of more than 2.7 million people
worldwide. Vaccination has started in most countries around the world. In this study, we …

[HTML][HTML] Economic evaluation of COVID-19 vaccination: A systematic review

AM Utami, F Rendrayani, QA Khoiry… - Journal of global …, 2023 - ncbi.nlm.nih.gov
Background Safe and effective vaccination is considered to be the most critical strategy to
fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity …

Cost‐effectiveness of COVID‐19 vaccination: A systematic review

Y Fu, J Zhao, P Han, J Zhang, Q Wang… - Journal of Evidence …, 2023 - Wiley Online Library
Objective The COVID‐19 vaccination strategy has been widely used to protect population
health worldwide. This study aims to summarize the cost‐effectiveness evidence of …

[HTML][HTML] COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness

CAB Pearson, F Bozzani, SR Procter, NG Davies… - PLoS …, 2021 - journals.plos.org
Background Multiple Coronavirus Disease 2019 (COVID-19) vaccines appear to be safe
and efficacious, but only high-income countries have the resources to procure sufficient …

[HTML][HTML] Economic evaluation for mass vaccination against COVID-19

WC Wang, JCY Fann, RE Chang, YC Jeng… - Journal of the Formosan …, 2021 - Elsevier
Background Vaccine is supposed to be the most effective means to prevent COVID-19 as it
may not only save lives but also reduce productivity loss due to resuming pre-pandemic …

[HTML][HTML] COVID-19 vaccines cost-effectiveness analysis: a scenario for Iran

A Vaezi, A Meysamie - Vaccines, 2021 - mdpi.com
COVID-19 vaccines are supposed to be critical measure for ending the pandemic.
Governments had to decide on the type of vaccine to provide for their population. In this …

The benefits of vaccinating with the first available COVID-19 coronavirus vaccine

SM Bartsch, KJ O'Shea, PT Wedlock, U Strych… - American journal of …, 2021 - Elsevier
Introduction During a pandemic, there are many situations in which the first available
vaccines may not have as high effectiveness as vaccines that are still under development or …

Cost-effectiveness analysis of COVID-19 vaccination in low-and middle-income countries

AM Utami, F Rendrayani, QA Khoiry… - Journal of …, 2022 - Taylor & Francis
Background WHO reported that 5.5 million people died in the world because of COVID-19.
One of the efforts to mitigate the pandemic is administrating the vaccines globally. Objective …

[HTML][HTML] Epidemiological differences in the impact of COVID-19 vaccination in the United States and China

M Makhoul, H Chemaitelly, HH Ayoub, S Seedat… - Vaccines, 2021 - mdpi.com
This study forecasts Coronavirus Disease 2019 (COVID-19) vaccination impact in two
countries at different epidemic phases, the United States (US) and China. We assessed the …

[HTML][HTML] Targeted vaccine allocation could increase the COVID-19 vaccine benefits amidst its lack of availability: A mathematical modeling study in Indonesia

A Fuady, N Nuraini, KK Sukandar, BW Lestari - Vaccines, 2021 - mdpi.com
With a limited number of vaccines and healthcare capacity shortages, particularly in low-and
middle-income countries, vaccination programs should seek the most efficient strategy to …